64821-19-8
中文名称
化合物MAO-IN-M30二盐酸盐
英文名称
VAR10300 dihydrochloride
CAS
64821-19-8
分子式
C14H16Cl2N2O
分子量
299.196
MOL 文件
64821-19-8.mol
更新日期
2026/01/19 16:51:11
64821-19-8 结构式
基本信息
中文别名
化合物MAO-IN-M30二盐酸盐 英文别名
M30 dihydrochlorideM-30 dihydrochloride
VAR10300 dihydrochloride
MAO-IN-M30 dihydrochloride
5-[[Methyl(2-propyn-1-yl)amino]methyl]-8-quinolinol Dihydrochloride
5-[N-methyl-N-propargylaminomethyl]-8-hydroxyquinoline dihydrochloride
N-(8-Hydroxy-5-quinolylmethyl)-N-methyl-2-propynylamine dihydrochloride
物理化学性质
储存条件2-8°C
溶解度DMSO、庚烷和二甲苯：≥21mg/mL
形态粉末
颜色黄绿色
水溶解性溶于水至100mM
InChI1S/C14H14N2O.2ClH/c1-3-9-16(2)10-11-6-7-13(17)14-12(11)5-4-8-15-14;;/h1,4-8,17H,9-10H2,2H3;2*1H
InChIKeyXJNICPXVRPOSSO-UHFFFAOYSA-N
SMILESCl.Cl.CN(CC#C)Cc1ccc(O)c2ncccc12
安全数据
化合物MAO-IN-M30二盐酸盐价格(试剂级)
| 报价日期 | 产品编号 | 产品名称 | CAS号 | 包装 | 价格 |
| 2025/12/22 | HY-131036 | 化合物MAO-IN-M30二盐酸盐 MAO-IN-M30 dihydrochloride | 64821-19-8 | 5mg | 620元 |
| 2025/12/22 | HY-131036 | 化合物MAO-IN-M30二盐酸盐 MAO-IN-M30 dihydrochloride | 64821-19-8 | 10 mg | 923元 |
| 2025/12/22 | HY-131036 | 化合物MAO-IN-M30二盐酸盐 MAO-IN-M30 dihydrochloride | 64821-19-8 | 25 mg | 1475元 |
常见问题列表
生物活性
MAO-IN-M30 dihydrochloride 是一种口服活性，可通过血脑屏障的，脑选择性不可逆 MAO-A (IC50=37 nM) 和 MAO-B (IC50=57 nM) 抑制剂。MAO-IN-M30 dihydrochloride 是有效的铁螯合剂、自由基清除剂。MAO-IN-M30 dihydrochloride 对 Dexamethasone 诱导的脑细胞凋亡具有神经保护作用。MAO-IN-M30 dihydrochloride 在 MPTP 和 lactacystin 帕金森病模型中也显示出神经恢复活性。靶点
|
MAO-A 37 nM (IC 50 ) |
MAO-B 57 nM (IC 50 ) |
体外研究
MAO-IN-M30 (0.25 nM; 72 hours) significantly increased cell viability to ~90% after exposure to Dexamethasone.
MAO-IN-M30 (0-10 μM; 24 hours) enhances PC12 cell survival.
MAO-IN-M30 treatment significantly decreases the occurrence of fragmented DNA compared to the dexamethasone-treated group in SH-SY5Y cells.
Cell Viability Assay
| Cell Line: | SH-SY5Y cells |
| Concentration: | 0.25 nM |
| Incubation Time: | 72 hours |
| Result: | Significantly increased cell viability to ∼90% after exposure to Dexamethasone. |
Cell Viability Assay
| Cell Line: | PC12 cells |
| Concentration: | 0-10 μM |
| Incubation Time: | 24 hours |
| Result: | Enhanced the PC12 cell viability, the cell viability increasing to 85 ± 6 and 90 ± 7%. |
体内研究
MAO-IN-M30 (0.5-2.5 mg/kg; p.o.; once daily for 14 consecutive days) possesses neuroprotective activities.
| Animal Model: | Male C57/BL mice (20-22 g; MPTP-induced neurotoxicity in mice) |
| Dosage: | 0.5, 2.5 mg/kg |
| Administration: | P.o.; once daily for 14 consecutive days |
| Result: | Significantly elevate striatal dopamine levels, reduce its metabolism, and elevate tyrosine-hydroxylase protein levels and activity. Elevated MPTP-reduced dopaminergic and transferrin receptor cell count in the SNpc. |